Related references
Note: Only part of the references are listed.Development and validation of an UHPLC-MS/MS method for simultaneous determination of palbociclib, letrozole and its metabolite carbinol in rat plasma and pharmacokinetic study application
Mona Al-Shehri et al.
ARABIAN JOURNAL OF CHEMISTRY (2020)
A Bioanalytical Method for Eliglustat Quantification in Rat Plasma
Venkata Krishna Reddy et al.
JOURNAL OF CHROMATOGRAPHIC SCIENCE (2019)
Development and validation of a bioanalytical method for the quantification of the CDK4/6 inhibitors abemaciclib, palbociclib, and ribociclib in human and mouse matrices using liquid chromatography-tandem mass spectrometry
Alejandra Martinez-Chavez et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2019)
Optimization and validation of RP-HPLC method for simultaneous estimation of palbociclib and letrozole
Yuvraj Dange et al.
TOXICOLOGY MECHANISMS AND METHODS (2018)
Optimization and validation of RP-HPLC method for simultaneous estimation of palbociclib and letrozole
Yuvraj Dange et al.
TOXICOLOGY MECHANISMS AND METHODS (2018)
Abemaciclib: a CDK4/6 inhibitor for the treatment of HR+/HER2-advanced breast cancer
Silvia Paola Corona et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Establishment of a quantitative bioanalytical method for an acetylcholinesterase inhibitor Ethyl 3-(2-(4-fluorophenyl) amino)-4-phenylthiazol-5-yl)-3-oxopropanoate including its physicochemical characterization and in vitro metabolite profiling using Liquid Chromatography-Mass Spectrometry
Kavya Sri Nemani et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2018)
Drug development and bioanalytical method validation for a novel anticancer molecule, 4-(dimethylamino)-2-(p-tolylamino) thiazole-5-carbonitrile
Nripendra Madhab Biswas et al.
DRUG DEVELOPMENT RESEARCH (2018)
MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
Matthew P. Goetz et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Assessment of preclinical pharmacokinetics and acute toxicity of pioglitazone and telmisartan combination
Pinaki Sengupta et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2017)
Development and validation of a high throughput LC-MS/MS method for simultaneous quantitation of pioglitazone and telmisartan in rat plasma and its application to a pharmacokinetic study
Pinaki Sengupta et al.
JOURNAL OF PHARMACEUTICAL ANALYSIS (2017)
Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Other Solid Tumors
Amita Patnaik et al.
CANCER DISCOVERY (2016)
SPE-UPLC-MS/MS assay for determination of letrozole in human plasma and its application to bioequivalence study in healthy postmenopausal Indian women
Pravin G. Vanol et al.
JOURNAL OF PHARMACEUTICAL ANALYSIS (2016)
Preliminary Results of a Phase 1b Study (GO28440) Combining GDC-0199 (ABT-199) with Bendamustine/Rituximab in Patients with Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia
Gilles Andre Salles et al.
BLOOD (2014)
Development and validation of an LC-ESI-MS/MS method for simultaneous quantitation of olmesartan and pioglitazone in rat plasma and its pharmacokinetic application
Pinaki Sengupta et al.
BIOMEDICAL CHROMATOGRAPHY (2010)
Effects of estrogen on breast cancer development: role of estrogen receptor independent mechanisms
Wei Yue et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
LC-MS-MS Development and Validation for Simultaneous Quantitation of Metformin, Glimepiride and Pioglitazone in Human Plasma and Its Application to a Bioequivalence Study
Pinaki Sengupta et al.
CHROMATOGRAPHIA (2009)
HPLC determination of letrozole in plasma using fluorescence detection: Application to pharmacokinetic studies
Afshin Zarghi et al.
CHROMATOGRAPHIA (2007)
Share Paper
